Global Blockchain as a Service (BaaS) Market (2018-2025)-GMI Research Global Artificial Intelligence | Page 4

• Cardiovascular Disease
• Oncology
• Neurodegenerative Diseases
•
Others
By End-Users
•
•
Pharmaceutical Companies
Biopharmaceutical Companies
• Academic and Research Institutes
• Others
By Geography
•
North America
As a part of customization
o By Drug Type
o By Technology Type
o By Therapeutic
o By End users
o US
o Canada
o Mexico
• Europe
As a part of customization
o By Drug Type
o By Technology Type
o By Therapeutic
o By End users
o UK
o Germany
o Spain
o Rest of Europe
• Asia-Pacific
As a part of customization
o
By Drug Type